Literature DB >> 16511644

Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 gene.

A Poujois, J-Ch Antoine, A Combes, R L Touraine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511644     DOI: 10.1007/s00415-006-0134-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  11 in total

1.  Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.

Authors:  L H Eunson; R Rea; S M Zuberi; S Youroukos; C P Panayiotopoulos; R Liguori; P Avoni; R C McWilliam; J B Stephenson; M G Hanna; D M Kullmann; A Spauschus
Journal:  Ann Neurol       Date:  2000-10       Impact factor: 10.422

2.  A role for hydrophobic residues in the voltage-dependent gating of Shaker K+ channels.

Authors:  K McCormack; M A Tanouye; L E Iverson; J W Lin; M Ramaswami; T McCormack; J T Campanelli; M K Mathew; B Rudy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 3.  Potassium channelopathies.

Authors:  M C Sanguinetti; P S Spector
Journal:  Neuropharmacology       Date:  1997-06       Impact factor: 5.250

4.  Determinants of 4-aminopyridine sensitivity in a human brain kv1.4 k(+) channel: phenylalanine substitutions in leucine heptad repeat region stabilize channel closed state.

Authors:  Susan I V Judge; Jay Z Yeh; James E Goolsby; Mervyn J Monteiro; Christopher T Bever
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

5.  A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.

Authors:  S M Zuberi; L H Eunson; A Spauschus; R De Silva; J Tolmie; N W Wood; R C McWilliam; J B Stephenson; J P Stephenson; D M Kullmann; M G Hanna
Journal:  Brain       Date:  1999-05       Impact factor: 13.501

6.  Identification of two new KCNA1 mutations in episodic ataxia/myokymia families.

Authors:  D L Browne; E R Brunt; R C Griggs; J G Nutt; S T Gancher; E A Smith; M Litt
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

7.  A novel mutation in KCNA1 causes episodic ataxia without myokymia.

Authors:  Hane Lee; Hui Wang; Joanna C Jen; Chiara Sabatti; Robert W Baloh; Stanley F Nelson
Journal:  Hum Mutat       Date:  2004-12       Impact factor: 4.878

8.  Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency.

Authors:  P Zerr; J P Adelman; J Maylie
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

9.  Hereditary myokymia and periodic ataxia.

Authors:  D H VanDyke; R C Griggs; M J Murphy; M N Goldstein
Journal:  J Neurol Sci       Date:  1975-05       Impact factor: 3.181

10.  Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia.

Authors:  M Kinali; H Jungbluth; L H Eunson; C A Sewry; A Y Manzur; E Mercuri; M G Hanna; F Muntoni
Journal:  Neuromuscul Disord       Date:  2004-10       Impact factor: 4.296

View more
  10 in total

Review 1.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

Review 2.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

Review 3.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 4.  Paroxysmal motor disorders: expanding phenotypes lead to coalescing genotypes.

Authors:  Laura Zima; Sophia Ceulemans; Gail Reiner; Serena Galosi; Dillon Chen; Michelle Sahagian; Richard H Haas; Keith Hyland; Jennifer Friedman
Journal:  Ann Clin Transl Neurol       Date:  2018-07-17       Impact factor: 4.511

5.  A Common Kinetic Property of Mutations Linked to Episodic Ataxia Type 1 Studied in the Shaker Kv Channel.

Authors:  Juan Zhao; Dimitri Petitjean; Georges A Haddad; Zarah Batulan; Rikard Blunck
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

6.  Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel.

Authors:  Paola Imbrici; Andrea Accogli; Rikard Blunck; Concetta Altamura; Michele Iacomino; Maria Cristina D'adamo; Anna Allegri; Marina Pedemonte; Noemi Brolatti; Stella Vari; Matteo Cataldi; Valeria Capra; Stefano Gustincich; Federico Zara; Jean-Francois Desaphy; Chiara Fiorillo
Journal:  Biomedicines       Date:  2021-01-14

7.  Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.

Authors:  Tracey D Graves; Yoon-Hee Cha; Angelika F Hahn; Richard Barohn; Mohammed K Salajegheh; Robert C Griggs; Brian N Bundy; Joanna C Jen; Robert W Baloh; Michael G Hanna
Journal:  Brain       Date:  2014-02-26       Impact factor: 13.501

Review 8.  New insights into the pathogenesis and therapeutics of episodic ataxia type 1.

Authors:  Maria Cristina D'Adamo; Sonia Hasan; Luca Guglielmi; Ilenio Servettini; Marta Cenciarini; Luigi Catacuzzeno; Fabio Franciolini
Journal:  Front Cell Neurosci       Date:  2015-08-19       Impact factor: 5.505

Review 9.  Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.

Authors:  Maria Cristina D'Adamo; Antonella Liantonio; Jean-Francois Rolland; Mauro Pessia; Paola Imbrici
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

10.  Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.

Authors:  Antonio Castellano; Aurora Pujol; Edgard Verdura; Carme Fons; Agatha Schlüter; Montserrat Ruiz; Stéphane Fourcade; Carlos Casasnovas
Journal:  J Med Genet       Date:  2019-10-05       Impact factor: 6.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.